| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/01/2006 | CA2587399A1 Cytokinin-sensing histidine kinases and methods of use |
| 06/01/2006 | CA2587139A1 Purification of recombinant human factor xiii |
| 05/31/2006 | EP1662255A2 Homer interacting proteins |
| 05/31/2006 | EP1662004A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1662000A2 Expression cassettes for guard cell-preferential expression in plants |
| 05/31/2006 | EP1661998A2 Antigenic polypeptides, antibodies binding thereto, nucleic acids encoding the antigens, and methods of use |
| 05/31/2006 | EP1661997A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661996A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/31/2006 | EP1661995A1 Method of diagnosing, monitoring, staging, imaging and treating colon cancer |
| 05/31/2006 | EP1661994A1 Therapeutic agent for NGF |
| 05/31/2006 | EP1661993A1 SLY1 inhibitors in organ, tissue and cell transplantation |
| 05/31/2006 | EP1661990A1 Polypeptide specific to liver cancer, polynucleotide encoding the polypeptide and rna molecule inhibiting the expression of the polypeptide |
| 05/31/2006 | EP1661989A1 Process for preparing recombinant cell having high fibrinogen production capability and cell having high production capability |
| 05/31/2006 | EP1661987A1 Corynebacterium glutamicum gene encoding phosphoenolpyruvate carboxykinase |
| 05/31/2006 | EP1661986A1 Nucleic acids and polypeptides enocoded thereby that are member of the kallikrein gene familyNovel nucleic acids and polypeptides |
| 05/31/2006 | EP1661913A1 Bioactive peptides derived from the proteins of egg white by means of enzymatic hydrolysis |
| 05/31/2006 | EP1661912A1 Fusion protein comprising a BH3-domain of a BH3-only protein |
| 05/31/2006 | EP1661911A1 Protease-resistant seb variant and vaccine containing the same |
| 05/31/2006 | EP1661908A1 Reagent for amplifying amyloid fibrosis of amyloid beta-protein |
| 05/31/2006 | EP1661907A1 A cardio myopeptidin, the production and the use thereof |
| 05/31/2006 | EP1661577A1 Therapeutic preparation for hematopoietic disease |
| 05/31/2006 | EP1660686A2 Hpv cd8+ t-cell epitopes |
| 05/31/2006 | EP1660678A2 Mutant adeno-associated virus virions and methods of use thereof |
| 05/31/2006 | EP1660665A2 Chimaeric vector system |
| 05/31/2006 | EP1660661A2 Methods of protein production in yeast |
| 05/31/2006 | EP1660660A2 Polypeptides of streptococcus pyogenes |
| 05/31/2006 | EP1660659A2 Gdnf-related neuropeptides |
| 05/31/2006 | EP1660654A1 Expression vector |
| 05/31/2006 | EP1660651A2 Ubp8rp polypeptides and their use in the treatment of psoriasis |
| 05/31/2006 | EP1660638A2 Lipoparticles comprising proteins, methods of making, and using the same |
| 05/31/2006 | EP1660636A2 Anti-cancer vaccines |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660628A2 SPLICE VARIANTS OF ErbB LIGANDS, COMPOSITIONS AND USES THEREOF |
| 05/31/2006 | EP1660539A2 Compounds comprising lpa |
| 05/31/2006 | EP1660535A2 Techniques and compositions for the diagnosis and treatment of cancer (muc1) |
| 05/31/2006 | EP1660532A1 Fusion polypeptides, and use thereof in antivascular tumor therapy |
| 05/31/2006 | EP1660530A2 Canine specific growth hormone releasing hormone |
| 05/31/2006 | EP1660529A2 Modified il-4 mutein receptor antagonists |
| 05/31/2006 | EP1660528A2 Muteins of tear lipocalin |
| 05/31/2006 | EP1660527A1 Isolated berovin photoprotein and use thereof |
| 05/31/2006 | EP1660526A1 Gastric and prostate cancer associated antigens |
| 05/31/2006 | EP1660525A1 Plant-derived peptides harboring water-cleaning and antimicrobial activities |
| 05/31/2006 | EP1660524A2 Identification of porphyromonas gingivalis virulence polynucleotides for diagnosis, treatment, and monitoring of periodontal diseases |
| 05/31/2006 | EP1660523A2 Induction of antiviral neutralizing antibodies in humans and animals |
| 05/31/2006 | EP1660520A1 One-step reduction and alkylation of proteins |
| 05/31/2006 | EP1660518A2 Complexes of gpcr142 and relaxin3 or insl5, and their production and use |
| 05/31/2006 | EP1660517A2 Nogo receptor antagonists |
| 05/31/2006 | EP1660514A2 A novel gene and protein associated with angiogenesis and endothelial apoptosis |
| 05/31/2006 | EP1660513A2 A ca6 antigen-specific cytotoxic conjugate and methods of using the same |
| 05/31/2006 | EP1660502A2 MODULATION OF ß-CATENIN/TCF ACTIVATED TRANSCRIPTION |
| 05/31/2006 | EP1660136A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 05/31/2006 | EP1660135A1 Method of treating hepatocellular carcinoma |
| 05/31/2006 | EP1660125A1 Composition for the prophylaxis/treatment of hbv infections and hbv-mediated diseases |
| 05/31/2006 | EP1660124A2 Antigenic peptides of rabies virus and uses thereof |
| 05/31/2006 | EP1660119A2 Multi-antigen vectors for melanoma |
| 05/31/2006 | EP1660114A1 Methods and compositions for treating disorders of the extracellular matrix |
| 05/31/2006 | EP1660113A1 A method of producing an anticoagulation effect |
| 05/31/2006 | EP1660016A2 Sars nucleic acids, proteins, vaccines, and uses thereof |
| 05/31/2006 | EP1660008A2 Therapeutic use of g53135-05(fgf-20) in radiation protection |
| 05/31/2006 | EP1660007A2 Compositions for diabetes treatment and prophylaxis |
| 05/31/2006 | EP1659919A2 Hemostatic devices containing a protein precipitate |
| 05/31/2006 | EP1659918A2 Antibodies directed to parathyroid hormone (pth) and uses thereof |
| 05/31/2006 | EP1659860A1 New diabetes type 2 animal model |
| 05/31/2006 | EP1659858A2 Transgenic mice having a human major histocompatibility complex (mhc) phenotype, experimental uses and applications |
| 05/31/2006 | EP1604032A4 Method for detecting prognosis of cancer |
| 05/31/2006 | EP1587928A4 Human saa3 nucleic acid molecule, protein, and methods of use for same |
| 05/31/2006 | EP1573041A4 Detection and typing of human papillomavirus using pna probes |
| 05/31/2006 | EP1534739A4 Identification of polynucleotides and polypeptide for predicting activity of compounds that interact with protein tyrosine kinases and/or protein tyrosine kinase pathways |
| 05/31/2006 | EP1470229B1 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state |
| 05/31/2006 | EP1455811A4 Isolated cryopyrins, nucleic acid molecules encoding these, and use thereof |
| 05/31/2006 | EP1419178B1 Somatostatin analogues and their use somatostatin analogues binding to all somatostatin receptor and their use |
| 05/31/2006 | EP1385960B1 Cocoa polypeptides and their use in the production of cocoa and chocolate flavour |
| 05/31/2006 | EP1346226B1 Screening method based on siah-numb interaction |
| 05/31/2006 | EP1322284B1 Method for obtaining an active principle with immediate skin-tightening effect and resulting active principle |
| 05/31/2006 | EP1313855B1 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1231270B1 Novel protein and dna thereof |
| 05/31/2006 | EP1230371B1 Method for producing recombinant interleucin-8 and interleucin-8 muteins and their use for screening il-8 receptor antagonists |
| 05/31/2006 | EP1212084B1 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1171454B1 Chimeric lyssavirus nucleic acids and polypeptides |
| 05/31/2006 | EP1115745B1 Purification of fibrinogen from fluids by precipitation and hydrophobic interaction chromatography |
| 05/31/2006 | EP1108014B1 Ehrlichia canis protein |
| 05/31/2006 | EP1105410A4 Purification of blood clotting proteins |
| 05/31/2006 | EP1000151B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN VARIOUS TISSUES |
| 05/31/2006 | EP0915156B1 IgA NEPHROPATHY-ASSOCIATED GENE |
| 05/31/2006 | EP0914437B1 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 05/31/2006 | EP0911342B1 Novel protein and process for producing the same |
| 05/31/2006 | EP0891426B1 Human bikunin |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0879246B1 Synthesis of vip analog |
| 05/31/2006 | EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 05/31/2006 | EP0791076B1 Diagnostic method and kit for determining kell blood group genotype |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | EP0631630B1 Control of male fertility using externally inducible promoter sequences |
| 05/31/2006 | CN1781021A N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 05/31/2006 | CN1780919A Methods and products based on oligomerization of stress proteins |
| 05/31/2006 | CN1780915A Tissue specific promoters |